Finzati - Logo
APUS logo

Apimeds Pharmaceuticals US, Inc

APUSBiotechnology
$2.42
-0.09 (-3.59%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$6.87M
Growth
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.05Healthy liquidity · 1.31Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 16, 2026, 12:23 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$2.42
Change-3.59%
Market Cap$6.87M
52W Range4.15 - 59.70
Beta0.15
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.05
Current Ratio1.31
Quick Ratio1.31
Volume21.17K

Investment DNA

How strong this company looks for long-term investors

47
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
68/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score
Manageable debt level · 0.05Healthy liquidity · 1.31Weak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 5/9/2025
Industry: Biotechnology
P/B i: 0.12
Debt / Equity i: 0.05
Operating Margin: 0.00%
Net Margin: 0.00%
ROE i: -
ROIC: -

Financial Health

Score14 / 20
Debt / Equity: 0.05
Current Ratio: 1.31
Quick Ratio: 1.31
Status: Good

Insider Transactions

Recent executive and insider activity

Inscobee Inc.
Transaction: 05/12/2024
OTHER
Change
0
Price
Not reported
Filing
11/21/2025
Type
OTHER
Kogan Elona
Transaction: 11/11/2025
BUY
Change
+10,000
Price
$2.67
Filing
11/13/2025
Type
BUY
O'DONNELL CAROL A
Transaction: 11/11/2025
BUY
Change
+10,000
Price
$2.67
Filing
11/13/2025
Type
BUY